Methodology: each issue's direction is a live signal — long/short opens or holds a position, neutral means flat, and every direction change opens, flips, or closes it. Returns are direction-aware (a short gains when the price falls) and compound across positions from first observation to the latest issue. "Price move" is the stock's own raw change, shown separately. Neither represents actual portfolio performance.
Brief History (4 issues)
Down 15.7% on the week at RSI 29, deeply oversold — the med-device leader shows no absorption yet; wait for a right-side signal before catching
De-ratings born of 'beat but no raise' typically need 2-3 quarters of data to appeal the verdict; the only short-term trade here is an oversold bounce, sized small with an iron stop
Up 3.4% on 2x volume to $402.33, a third straight gain as the medtech repair takes shape — right-sided, but the chase math is mediocre; sidelines
Up 2.5% on 1.6x volume to $388.97 — the surgical-robot leader snaps back from a 36% crater; right side unproven, watching